ranolazine (Q907104): Difference between revisions

From Wikidata
Jump to navigation Jump to search
Updated Item: Added drug-drug interaction.
Updated Item: Added drug-drug interaction.
Property / significant drug interaction
 
Property / significant drug interaction: Ketoconazole / rank
 
Normal rank
Property / significant drug interaction: Ketoconazole / qualifier
 
Property / significant drug interaction: Ketoconazole / reference
 

Revision as of 13:26, 6 December 2023

drug to treat angina that was first approved in 2006.
  • CVT-303
  • Ranexa®
  • RS-43285
  • RS-43285-003
  • Ranolazine
  • N-(2,6-Dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide
Language Label Description Also known as
English
ranolazine
drug to treat angina that was first approved in 2006.
  • CVT-303
  • Ranexa®
  • RS-43285
  • RS-43285-003
  • Ranolazine
  • N-(2,6-Dimethylphenyl)-2-[4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl]acetamide

Statements

0 references
427.247107 dalton
1 reference
C₂₄H₃₃N₃O₄
1 reference
CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O
1 reference
Ranolazine
0 references

Identifiers

1 reference
28 October 2019
Ranolazine (English)
10 May 2021
0 references
0 references
620-450-7
1 reference
27 December 2018
N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide (English)
CAS no.: 95635-55-5 (English)
1 reference
27 December 2018
N-(2,6-dimethylphenyl)-2-{4-[2-hydroxy-3-(2-methoxyphenoxy)propyl]piperazin-1-yl}acetamide (English)
CAS no.: 95635-55-5 (English)
0 references